Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950135-98-001066
Filing Date
1998-02-17
Accepted
1998-02-17 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 TRANSCEND THERAPEUTICS, INC. SC 13G 7269
  Complete submission text file 0000950135-98-001066.txt   9126
Mailing Address 200 PARK AVENUE NEW YORK NY 10166
Business Address 200 PARK AVENUE NEW YORK NY 10166
BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Filed by) CIK: 0000938017 (see all company filings)

 

Mailing Address 640 MEMORIAL DR 3W CAMBRIDGE MA 02139
Business Address 640 MEMORIAL DR 3W CAMBRIDGE MA 02139 6173741200
TRANSCEND THERAPEUTICS INC (Subject) CIK: 0001020910 (see all company filings)

EIN.: 043174575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-52371 | Film No.: 98542181
SIC: 2836 Biological Products, (No Diagnostic Substances)